94. Primary sclerosing cholangitis Clinical trials / Disease details
Clinical trials : 148 / Drugs : 118 - (DrugBank : 39) / Drug target genes : 18 - Drug target pathways : 141
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02424175 (ClinicalTrials.gov) | February 1, 2016 | 18/4/2015 | Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis. | Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis. | Sclerosing Cholangitis | Biological: Fecal Microbiota Transplantation | Brigham and Women's Hospital | NULL | Completed | 18 Years | N/A | All | 10 | Phase 1/Phase 2 | United States |